When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often.
Publication
, Journal Article
Patrick-Lake, B; Hernandez, AF
Published in: JAMA Cardiol
November 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
November 1, 2017
Volume
2
Issue
11
Start / End Page
1269 / 1270
Location
United States
Related Subject Headings
- Humans
- Clinical Trials as Topic
- Caregivers
- Cardiovascular System
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Patrick-Lake, B., & Hernandez, A. F. (2017). When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often. JAMA Cardiol, 2(11), 1269–1270. https://doi.org/10.1001/jamacardio.2017.3607
Patrick-Lake, Bray, and Adrian F. Hernandez. “When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often.” JAMA Cardiol 2, no. 11 (November 1, 2017): 1269–70. https://doi.org/10.1001/jamacardio.2017.3607.
Patrick-Lake B, Hernandez AF. When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often. JAMA Cardiol. 2017 Nov 1;2(11):1269–70.
Patrick-Lake, Bray, and Adrian F. Hernandez. “When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often.” JAMA Cardiol, vol. 2, no. 11, Nov. 2017, pp. 1269–70. Pubmed, doi:10.1001/jamacardio.2017.3607.
Patrick-Lake B, Hernandez AF. When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often. JAMA Cardiol. 2017 Nov 1;2(11):1269–1270.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
November 1, 2017
Volume
2
Issue
11
Start / End Page
1269 / 1270
Location
United States
Related Subject Headings
- Humans
- Clinical Trials as Topic
- Caregivers
- Cardiovascular System
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology